Financialsexperimental
MARIMED INC. (MRMD). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands
| Cash Flow | FY FY25 31 Dec 2025 | FY FY24 31 Dec 2024 | FY FY23 31 Dec 2023 | FY FY22 31 Dec 2022 | FY FY21 31 Dec 2021 |
|---|---|---|---|---|---|
| Net loss attributable to common stockholders | -14,484 | -12,164 | -16,031 | 13,468 | 7,224.5 |
| Net income attributable to noncontrolling interests | 28 | 37 | 24 | 146 | 399 |
| Depreciation and amortization of property and equipment | 3,432 | 2,097.7 | |||
| Depreciation and amortization of property and equipment | 8,109 | 7,910 | 5,549 | ||
| Amortization of intangible assets | 3,401 | 2,948 | 3,025 | 1,282 | 690.3 |
| Amortization of stock grants | 235.4 | ||||
| Stock-based compensation | 6,338 | ||||
| Stock-based compensation | 1,860 | 1,050 | 1,020 | ||
| Amortization of option grants | 12,494.2 | ||||
| Amortization of standalone warrant issuances | 0 | ||||
| Amortization of debt discount | 459 | 358 | 2,851 | ||
| Amortization of warrants issued as payment for services received | 0 | 218 | |||
| Amortization of original debt issuance discount | 0 | 232 | 0 | ||
| Amortization of warrants attached to debt | 0 | ||||
| Amortization of debt issuance costs | 73 | 73 | |||
| Amortization of stand-alone warrant issuances | 832,105 | ||||
| Amortization of beneficial conversion feature | 0 | ||||
| Payment-in-kind interest | 30 | 104 | 366 | ||
| Amortization of warrants attached to debt | 539,272 | ||||
| Bad debt expense | 1,582 | -336 | 118 | 3,752 | 1,862.4 |
| Amortization of warrants issued with stock | 654,681 | ||||
| Fees paid with stock | 1,107.7 | ||||
| Obligations settled with common stock | 3 | 10 | 465 | 696 | |
| Present value adjustment of notes payable | 0 | ||||
| Amortization of beneficial conversion feature | 176,522 | ||||
| Loss on disposal of assets | -834 | -13 | |||
| Amortization of original issue discount | 51,753 | ||||
| Loss on obligations settled with equity | 0 | -2.5 | |||
| Gain on extinguishment of debt | -0 | 10,431 | |||
| Write-off of disposed assets | 906 | ||||
| Loss on changes in fair value of investments | 0 | -145 | -76 | -1,106.6 | |
| Gain on sale of investment | 0 | ||||
| Accounts receivable, net | -429 | -1,207 | -3,160 | -6,902 | -4,697.1 |
| Loss on changes in fair value of investments | 1,082 | ||||
| Gain on finance lease adjustment | 0 | 31 | |||
| Deferred rents receivable | -12 | -74 | -74 | -132 | -262.5 |
| Other investment income | -954 | ||||
| Writedown of prepaid purchase consideration | 0 | 200 | |||
| Inventory | -6 | -8,182 | -5,829 | -5,383 | -2,937.3 |
| Gain on investment | -309,212 | ||||
| Other current assets | 1,035 | 883 | 4,500 | -5,219 | -868.2 |
| Other investment income | 0 | ||||
| Other assets | -2,606 | 1,421 | -356 | -126 | -17.5 |
| Accounts payable | 841 | 4,188 | 2,375 | 1,027 | 104.6 |
| Accrued expenses and other | 3,162 | 1,754 | -1,840 | -482 | -1,433.7 |
| Deferred revenue | 65 | ||||
| Income taxes payable | 3,726 | 7,488 | 2,945 | -4,978 | 15,571.5 |
| Net cash provided by operating activities | 7,695 | 6,785 | 7,910 | 7,311 | 35,854.8 |
| Sales and excise taxes payable | 744.1 | ||||
| Purchases of property and equipment | -1,167 | -11,960 | -20,130 | -12,140 | -17,873.6 |
| Operating lease payments, net | -19.4 | ||||
| Business combinations, net of cash acquired, and asset purchases | -231 | 4,250 | 2,987 | 12,847 | |
| Finance lease interest payments | 1.5 | ||||
| Advances toward future business combinations and asset purchases | 50 | 100 | 1,125 | ||
| Purchases of investments | 0 | 261 | |||
| Other current liabilities | -21.7 | ||||
| Business acquisitions, net of cash acquired | -692,070 | ||||
| Purchases and renewals of cannabis licenses | -465 | -712 | -626 | -601 | |
| Advances toward future business acquisitions | -800 | ||||
| Proceeds from notes receivable | 26 | 50 | 99 | 173 | |
| Acquisition of interest in subsidiary | 0 | ||||
| Net cash used in investing activities | -1,380 | -17,133 | -25,985 | -26,244 | -16,623.8 |
| Return on investment | 0 | 44 | |||
| Proceeds from sale of investment | 0 | 1,475 | |||
| Proceeds from disposal of assets | 45 | 22 | |||
| Investment in Green Growth Group, Inc. | -10 | ||||
| Due from third party | 0 | 227 | 76 | 29 | |
| Proceeds from mortgages | 2,000 | 1,163 | 0 | ||
| Interest on notes receivable | 476.9 | ||||
| Payment of third-party debt issuance costs in connection with debt | 9 | 0 | 3,339 | ||
| Issuance of notes receivable | 0 | 879 | |||
| Principal payments of mortgages | -1,495 | -382 | -585 | ||
| Proceeds from Construction to Permanent Commercial Real Estate Mortgage Loan | 0 | 5,077 | 53,618 | ||
| Repayment and retirement of mortgages | 689 | 0 | 12,595 | ||
| Proceeds from issuance of preferred stock | 0 | 23,000 | |||
| Principal payments of promissory notes | -3,066 | -1,177 | -2,370 | ||
| Principal payments of finance leases | -1,317 | -1,557 | -702 | -227 | -34.8 |
| Equity issuance costs | 0 | 387 | |||
| Distributions | -137 | -139 | -158 | -259 | -409.9 |
| Proceeds from issuance of promissory notes | 0 | 35.1 | |||
| Net cash used in financing activities | -4,713 | 2,985 | 22,983 | -1,013 | 7,453 |
| Net decrease in cash and cash equivalents | 1,602 | -7,363 | 4,908 | -19,946 | 26,684 |
| Proceeds from term loan | 0 | 29,100 | 3,000 | 2,700 | |
| Cash and equivalents, beginning of year | 7,282 | 14,645 | 9,737 | 29,683 | 2,999.1 |
| Proceeds from exercise of warrants | 0 | 92.8 | |||
| Cash and cash equivalents, end of period | 8,884 | 7,282 | 14,645 | 9,737 | 29,683 |
| Repayment of loans from related parties | 0 | -1,157.8 | |||
| Cash paid for interest | 6,910 | 6,689 | 5,654 | 1,744 | 1,975.2 |
| Principal payments of term loan | 0 | 1,800 | 617.4 | ||
| Cash paid for income taxes | -713 | 877 | 6,419 | 14,567 | 620.8 |
| Repayment and retirement of term loan, including paid-in-kind interest | 0 | 28,541 | |||
| Payment of penalties on early retirement of debt | 0 | 4,251 | |||
| Notes payable issued to purchase property and equipment | 447 | 396 | 158 | ||
| Entry into new finance leases | 1,297 | 2,881 | 3,235 | 794 | |
| Conversion of promissory notes | -3,821.4 | ||||
| Repayment and retirement of promissory notes | 0 | 5,503 | 1,537 | 15,806.6 | |
| Proceeds from exercise of stock options | 0 | 109 | 10 | 38.6 | |
| Common stock issued to purchase property and equipment | 0 | 0 | 300 | 300 | |
| Redemption of minority interests | 0 | 2,000 | |||
| Return of stock to the Company in connection with withholding taxes | 83 | ||||
| Operating lease right-of-use assets and liabilities | 466.1 | ||||
| Present value of promissory notes issued as purchase consideration | 0 | 3,000 | 4,569 | 4,348 | |
| Write-off of finance leases | 0 | 1,112 | |||
| Common stock issued as purchase consideration | 0 | 991 | 2,994 | 2,212 | |
| Common stock issued under licensing agreement | 0 | 10 | 5 | 121 | |
| Entry into new operating leases | 661,000 | ||||
| Conversion of preferred stock to common stock | 4,275 | 0 | 18,725 | ||
| Adjustment to purchase price allocation to reclassify certain acquired intangible assets to goodwill | 0 | -3,819 | |||
| Trade receivables converted to notes receivable | 7,843,910 | ||||
| Conversion of debentures payable | 0 | ||||
| Trade receivables converted to notes receivable | 0 | 750 | |||
| Conversion of debentures payable | 1,356,452 | ||||
| Conversion of promissory notes to equity | 0 | 400 | |||
| Acquisition of 30% interest in subsidiary | 975,360 | ||||
| Entry into new operating leases | 0 | 5,604 | |||
| Purchase of property with stock | 705,000 | ||||
| Common stock issued to settle obligations | 51,000 | ||||
| Return of stock | 9,937 | ||||
| Common stock issued to purchase minority interest in a subsidiary of the Company | 0 | 5 | |||
| Issuance of common stock associated with subscriptions | 5,365 | ||||
| Warrants to issue common stock issued with debt | 0 | 5,454 | |||
| Cashless exercise of warrants | 180 | ||||
| Liability recorded for building improvements | 0 | 1,997 | |||
| Cashless exercise of stock options | 106 | ||||
| Common stock issued to settle obligations | 0 | 160 | 275 | ||
| Issuance of common stock associated with subscriptions | 0 | 41 | 0 | ||
| Conversion of notes receivable to omnibus long-lived asset | 0 | 10,233 | |||
| Return of common stock to the Company in connection with withholding taxes | 41 | 0 |